Abstract:Five oxovanadium(IV) complexes, which were divided into two groups, [(VO)-O-IV(bhbb, nhbb)(H2O)(2)] (tridentate ligands: H(2)bhbb = 2-(5-bromo-2-hydroxylbenzylideneamino) benzoic acid, 1; H(2)nhbb = 2-(5-nitro-2-hydroxylbenzylideneamino) benzoic acid, 2) and [(VO)-O-IV(cpmp, bpmp, npmp)(2)] (bidentate ligands: Hcpmp = 4-chloro-2-((phenylimino) methyl) phenol, 3; Hbpmp = 4-bromo-2-((phenylimino) methyl)phenol, 4; Hnpmp = 4-nitro-2-((phenylimino) methyl) phenol, 5) have been prepared and characterized by elemental analysis, infrared, UV-visible and electrospray ionization mass spectrometry. The coordination in [(VO)-O-IV(bhbb)(H2O)(2)] (1) was confirmed by X-ray crystal structure analysis. The oxidation state of V(IV) with d(1) configuration in 1-5 was confirmed by EPR. The speciation of VO/H(2)bhbb in methanol-aqueous solution was investigated by potentiometric pH titrations. The result indicated that the main species were [(VO)-O-IV(bhbb)(OH)](-) and [(VO)-O-IV(bhbb)(OH)(2)](2-) at the pH range 7.0-7.4. The structure-activity relationship of the vanadium complexes in inhibiting protein tyrosine phosphatases (protein tyrosine phosphatase 1B, PTP1B; T-cell protein tyrosine phosphatase, TCPTP; megakaryocyte protein-tyrosine phosphatase, PTP-MEG2; Src homology phosphatase 1, SHP-1 and Src homology phosphatase 2, SHP-2) was investigated. The oxovanadium(IV) complexes were potent inhibitors of PTP1B, TCPTP, PTP-MEG2, SHP-1 and SHP-2, but exhibited different inhibitory abilities over different PTPs. Complexes 2 and 4 displayed better selectivity to PTP1B over the other four PTPs. Kinetic data showed that complex 2 inhibited PTP1B, TCPTP and SHP-1 with a noncompetitive inhibition mode, but a classical competitive inhibition mode for PTP-MEG2 and SHP-2. The results demonstrated that both the structures of vanadium complexes and the conformations of PTPs influenced PTP inhibition activity. The proper modification of the organic ligand moieties may result in screening potent and selective vanadium-based PTP1B inhibitors.

Synthesis and Characterization of Oxidovanadium Complexes As Enzyme Inhibitors Targeting Dipeptidyl Peptidase IV.

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Dipeptidyl Peptidase IV(DPP IV): a Novel Emerging Target for the Treatment of Type 2 Diabetes

Synthesis, Crystal Structures and Insulin-Like Activity of Two New Oxidovanadium(v) Complexes with Aroylhydrazones and Maltol Mixed-Ligands

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Synthesis, Crystal Structures and Insulin-Like Activity of Three New Oxidovanadium(v) Complexes with Aroylhydrazone Ligand.

Synthesis, Structures, and Insulin-Like Activity of Oxidovanadium(v) Complexes Derived from 2-Chloro-n′-(3-ethoxy-2-hydroxybenzylidene)benzohydrazide

Insulin-enhancing Activity of a Dinuclear Vanadium Complex: 5-Chloro-salicylaldhyde Ethylenediamine Oxovanadium(v) and Its Permeability and Cytotoxicity.

Synthesis, Structures and Insulin-Like Activity of Oxidovanadium(v) Complexes with Aroylhydrazones and Ethylmaltol Mixed-Ligands

Ternary Oxovanadium(iv) Complexes of ONO-donor Schiff Base and Polypyridyl Derivatives As Protein Tyrosine Phosphatase Inhibitors: Synthesis, Characterization, and Biological Activities

Schiff base oxovanadium complexes resist the assembly behavior of human islet amyloid polypeptide.

In Vivo Insulin-Mimetic Activity of [N,n′-1,3-propyl-bis(salicyladimine)]oxovanadium(iv)

Design, Synthesis and Biological Evaluation of Novel Imidazolone Derivatives As Dipeptidyl Peptidase 4 Inhibitors.

Synthesis and Evaluation of Oxovanadium(Iv) Complexes of Schiff-Base Condensates from 5-Substituted-2-hydroxybenzaldehyde and 2-Substituted-benzenamine As Selective Inhibitors of Protein Tyrosine Phosphatase 1B

Syntheses, Characterization, and Crystal Structures of Two Oxovanadium(V) Complexes with Insulin-like Activity

Synthesis, Characterization, and Insulin-Enhancing of Vanadium(V) Complexes with Similar Schiff Base Ligands

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects

Synthesis and Biological Evaluation of Novel Benzyl-Substituted (S)-Phenylalanine Derivatives As Potent Dipeptidyl Peptidase 4 Inhibitors.

Synthesis, Characterization and Anti-Diabetic Therapeutic Potential of a New Benzyl Acid-Derivatized Kojic Acid Vanadyl Complex

A Novel PTP1b Inhibitor Vanadium-Flavone Complex: Synthesis and Pharmacodynamic Evaluation in Streptozotocin-Induced Diabetic Mice